Landscapes / Companies
Actithera INC. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 2
Drugs
3
in active trials · 0 checked
Trials
1 active
1 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
-FAPI-74not checked |
— |
Phase 1/2 | 31 Jul 2029Phase 1/2 trial completes | ||
| Next date | 31 Jul 2029 · Phase 1/2 trial completes | ||||
| Also tested for | FAP-expressing Solid Tumors, Pancreatic Ductal Adenocarcinoma (PDAC) and 1 more | ||||
| Open drug page | |||||
177Lu-ACT319not checked |
— |
Phase 1/2 | 31 Jul 2029Phase 1/2 trial completes | ||
| Next date | 31 Jul 2029 · Phase 1/2 trial completes | ||||
| Also tested for | FAP-expressing Solid Tumors, Pancreatic Ductal Adenocarcinoma (PDAC) and 1 more | ||||
| Open drug page | |||||
177Lu-ACT319 atnot checked |
— |
Phase 1/2 | 31 Jul 2029Phase 1/2 trial completes | ||
| Next date | 31 Jul 2029 · Phase 1/2 trial completes | ||||
| Also tested for | FAP-expressing Solid Tumors, Pancreatic Ductal Adenocarcinoma (PDAC) and 1 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021